UCLA gene therapy pioneer Dr. Donald Kohn elected to National Academy of Medicine
Grant and Award Announcement
Updates every hour. Last Updated: 24-Oct-2026 12:17 ET (24-Oct-2026 16:17 GMT/UTC)
Dr. Donald Kohn, a UCLA physician-scientist whose work has helped bring life-saving blood stem cell gene therapies from the laboratory to patients with blood and immune diseases, has been elected to the National Academy of Medicine, one of the highest honors in the fields of health and medicine.
Percival, an AI model developed at Penn Medicine, can detect health issues and unearth potential risks through CT scans, even for issues the imaging wasn’t ordered for.
Gladstone Institutes scientists Melanie Ott, MD, PhD, and Alex Marson, MD, PhD, have earned one of the highest honors in health and medicine with their election to the National Academy of Medicine.
Nikki Thiele, a staff scientist in the Chemical Sciences Division of the Department of Energy’s Oak Ridge National Laboratory, has received a 2026 NIH Director’s New Innovator Award. The five-year National Institutes of Health grant supports innovative research with the potential for broad impact on biomedical and behavioral science. Thiele will develop innovative chelator designs to improve targeted radiopharmaceuticals.
A new MUSC study published in JAMA Pediatrics reveals a striking reversal in youth vaping trends: Girls are now vaping at higher rates than boys. Among teens ages 15 to 17, regular vaping among girls rose from 4.9% in 2021 to 7.8% in 2024, compared with 4.6% of boys. Although cigarette smoking among adolescents has fallen to historic lows, researchers warn that nicotine addiction remains a serious concern. “We have to sound the alarm bells for girls,” said Benjamin Toll, Ph.D., of MUSC Hollings Cancer Center. “But we also need to make sure that we’re addressing the boys, too.” The findings highlight the need for targeted prevention and treatment efforts to address changing patterns of youth nicotine use.
People with ADHD face higher mortality rates, but taking medication may mitigate this risk, finds a study led by UCL and University of Liverpool researchers.
An international clinical trial found that adults with major depression can successfully complete a six-week course of home-based brain stimulation combined with a video game after up to five instructional clinic visits. The study, conducted through clinical centers in Jerusalem, Riga, and Munich, achieved its primary objective by demonstrating the feasibility of remote treatment. However, the experimental combination of active transcranial direct current stimulation (tDCS) and computerized cognitive training did not lead to greater improvement than a “double-sham” control condition combining sham brain stimulation with a control game. Both groups showed a marked reduction in depressive symptoms, raising important questions about which elements of the treatment experience may contribute to improvement.